Syntheses of new tuberculosis inhibitors promoted by microwave irradiation

References

• Koch R. Die Ätiologie der Tuberkulose. Berliner Klinischen Wochenschrift. 1882;19:221–30.
   Google Scholar
• Koch R. The etiology of tuberculosis. Rev Infect Dis. 1982;4:1270–4.
   PubMedGoogle Scholar
• Daniel TM. The history of tuberculosis. Respir Med. 2006;100:1862–70.
   PubMed Web of Science ®Google Scholar
• Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasit. 2006;100:415–31.
   PubMed Web of Science ®Google Scholar
• Verma I, Grover A. Antituberculous vaccine development: a perspective for the endemic world. Expert Rev Vaccines. 2009;8:1547–53.
   PubMed Web of Science ®Google Scholar
• Tuberculosis control and research strategy for the 1990s. World Health Organization: Geneva, 26–27 October, 1991.
   Google Scholar
• Palomino JC, Martin A. TMC207 becomes bedaquiline, a new anti-TB drug. Future Microbiol. 2013;8:1071–80.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis control: a short update to the 2009 report. Geneva: World Health Organization; 2009.
   Google Scholar
• Dye C, Lonnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ. 2009;87:683–91.
   PubMed Web of Science ®Google Scholar
• Ax A, Schaal W, Vrang L, Samuelsson B, Hallberg A, Karlén A. Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2′ to P1/P1′. Bioorg Med Chem. 2005;13:755–64.
   PubMed Web of Science ®Google Scholar
• Bacaer N, Ouifki R, Pretorius C, Wood R, Williams B. Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol. 2008;57:557–93.
   PubMed Web of Science ®Google Scholar
• Global tuberculosis report. Geneva: World Health Organization: 2013.
   Google Scholar
• Aubry A, Fisher LM, Jarlier V, Cambau E. First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis. Biochem Biophys Res Commun. 2006;348:158–65.
   Google Scholar
• Johnsson K, King DS, Schultz PG. Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J Am Chem Soc. 1995;117:5009–10.
   Web of Science ®Google Scholar
• Shakil S, Khan R, Zarrilli R, Khan AU. Aminoglycosides versus bacteria: a description of the action, resistance mechanism, and nosocomial battleground. J Biomed Sci. 2008;15:5–14.
   PubMed Web of Science ®Google Scholar
• Kappe CO. Microwave dielectric heating in synthetic organic chemistry. Chem Soc Rev. 2008;37:1127–39.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Gold H, Larhed M, Hallberg A. Microwave-assisted enantioselective Heck reactions: expediting high reaction speed and preparative convenience. Synthesis. 2002;11:1611–14.
   Google Scholar
• Noteberg D, Schaal W, Hamelink E, Vrang L, Larhed M. High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II. J Comb Chem. 2003;5:456–64.
   PubMed Web of Science ®Google Scholar
• Wannberg J, Ersmark K, Larhed M. Microwave-accelerated synthesis of protease inhibitors. Top Curr Chem. 2006;266:167–98.
   Google Scholar
• Gising J, Odell LR, Larhed M. Microwave-assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV/AIDS, malaria and hepatitis C. Org Biomol Chem. 2012;10:2713–29.
   PubMed Web of Science ®Google Scholar
• Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–44.
   PubMed Web of Science ®Google Scholar
• Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, et al. The complete genome sequence of Escherichia coli K-12. Science. 1997;277:1453–62.
   PubMed Web of Science ®Google Scholar
• Kale GM, Raichurkar A, Hameed SP, Waterson D, McKinney D, Manjunatha MR, et al. Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA gyrase B. J Med Chem. 2013;56:8834–48.
   PubMed Web of Science ®Google Scholar
• Larhed M, Hallberg A. Microwave-promoted palladium-catalyzed coupling reactions. J Org Chem. 1996;61:9582–4.
   Web of Science ®Google Scholar
• Wu X, Ohrngren P, Joshi AA, Trejos A, Persson M, Arvela RK, et al. Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors. J Med Chem. 2012;55:2724–36.
   Google Scholar
• Guerrini V, De Rosa M, Pasquini S, Mugnaini C, Brizzi A, Cuppone AM, et al. New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains. Tuberculosis. 2013;93:405–11.
   Google Scholar
• Onajole OK, Pieroni M, Tipparaju SK, Lun S, Stec J, Chen G, et al. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains. J Med Chem. 2013;56:4093–103.
   PubMed Web of Science ®Google Scholar
• Shirude PS, Madhavapeddi P, Tucker JA, Murugan K, Patil V, Basavarajappa H, et al. Aminopyrazinamides: novel and specific gyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis. ACS Chem Biol. 2013;8:519–23.
   Google Scholar
• Harth G, Clemens DL, Horwitz MA. Glutamine-synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci USA. 1994;91:9342–6.
   PubMed Web of Science ®Google Scholar
• Clemens DL, Horwitz MA. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med. 1995;181:257–70.
   PubMed Web of Science ®Google Scholar
• Gordon AH, Darcyhart P, Young MR. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature. 1980;286:79–80.
   PubMed Web of Science ®Google Scholar
• Harth G, Horwitz MA. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med. 1999;189:1425–35.
   PubMed Web of Science ®Google Scholar
• Harth G, Horwitz MA. Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo. Infect Immun. 2003;71:2297–8.
   Google Scholar
• Gising J, Nilsson MT, Odell LR, Yahiaoui S, Lindh M, Iyer H, et al. Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors. J Med Chem. 2012;55:2894–8.
   PubMed Web of Science ®Google Scholar
• Odell LR, Russo F, Larhed M. Molybdenum hexacarbonyl mediated CO gas-free carbonylative reactions. Synlett. 2012;23:685–98.
   Google Scholar
• Nordqvist A, Nilsson MT, Lagerlunda O, Muthas D, Gising J, Yahiaoui S, et al. Synthesis, biological evaluation and X-ray crystallographic studies of imidazo[1,2-a]pyridine-based Mycobacterium tuberculosis glutamine synthetase inhibitors. Medchemcomm. 2012;3:620–6.
   Google Scholar
• Odell LR, Nilsson MT, Gising J, Lagerlund O, Muthas D, Nordqvist A, et al. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors. Bioorg Med Chem Lett. 2009;19:4790–3.
   Google Scholar
• Jose GS, Jackson ER, Uh E, Johny C, Haymond A, Lundberg L, et al. Design of potential bisubstrate inhibitors against Mycobacterium tuberculosis (Mtb) 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr)-evidence of a novel binding mode. Medchemcomm. 2013;4:1099–104.
   Google Scholar
• Andaloussi M, Henriksson LM, Wieckowska A, Lindh M, Björkelid C, Larsson AM, et al. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-d-xylulose 5-phosphate reductoisomerase. J Med Chem. 2011;54:4964–76.
   PubMed Web of Science ®Google Scholar
• Nordqvist A, Bjorkelid C, Andaloussi M, Jansson AM, Mowbray SL, Karlen A, et al. Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors. J Org Chem. 2011;76:8986–98.
   Google Scholar
• Zhou Y, Beeler AB, Cho SY, Wang YH, Franzblau SG, Snyder JK. Library synthesis using 5,6,7,8-tetrahydro-1,6-naphthyridines as scaffolds. J Comb Chem. 2008;10:534–40.
   Google Scholar
• Lin G, Li DY, de Carvalho LPS, Deng HT, Tao H, Vogt G, et al. Inhibitors selective for mycobacterial versus human proteasomes. Nature. 2009;461:621–63.
   PubMed Web of Science ®Google Scholar
• Ohrngren P, Fardost A, Russo F, Schanche JS, Fagrell M, Larhed M. Evaluation of a nonresonant microwave applicator for continuous-flow chemistry applications. Org Process Res Dev. 2012;16:1053–63.
   Web of Science ®Google Scholar
• Biava M, Porretta GC, Poce G, De Logu A, Saddi M, Meleddu R, et al. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings. J Med Chem. 2008;51:3644–8.
   Google Scholar
• Biava M, Porretta GC, Poce G, De Logu A, Meleddu R, De Rossi E, et al. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation. Eur J Med Chem. 2009;44:4734–8.
   PubMedGoogle Scholar
• Manna K, Agrawal YK. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbony1-4-oxo-naphthyridin analogs. Eur J Med Chem. 2010;45:3831–9.
   PubMed Web of Science ®Google Scholar
• Alvey L, Prado S, Saint-Joanis B, Michel S, Koch M, Cole SI, et al. Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity. Eur J Med Chem. 2009;44:2497–505.
   PubMed Web of Science ®Google Scholar
• Kim P, Kang S, Boshoff HI, Jiricek J, Collins M, Singh R, et al. Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships. J Med Chem. 2009;52:1329–44.
   Google Scholar